We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TACO
2451
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $335K | ﹤0.01% |
25,266
+988
| +4% | +$13.2K |
|
2452
LeMaitre Vascular
LMAT
$2.34B
| $334K | ﹤0.01% |
13,556
+835
| +7% | +$19.6K |
|
|
ZGNX
2453
DELISTED
Zogenix, Inc.
ZGNX
| $334K | ﹤0.01% |
30,819
+2,820
| +10% | +$28.6K |
|
2454
1-800-Flowers.com
FLWS
$246M
| $333K | ﹤0.01% |
32,651
+1,140
| +4% | +$11.4K |
|
|
TUES
2455
DELISTED
Tuesday Morning Corp
TUES
| $333K | ﹤0.01% |
88,698
+23,704
| +36% | +$96.4K |
|
|
SFS
2456
DELISTED
Smart & Final Stores, Inc.
SFS
| $333K | ﹤0.01% |
27,515
+2,484
| +10% | +$33.9K |
|
|
ZEUS
2457
DELISTED
Olympic Steel
ZEUS
| $332K | ﹤0.01% |
17,872
+4,745
| +36% | +$108K |
|
2458
Atkore
ATKR
$2.4B
| $330K | ﹤0.01% |
12,558
+1,111
| +10% | +$28.6K |
|
2459
Titan Machinery
TITN
$413M
| $328K | ﹤0.01% |
21,364
+633
| +3% | +$8.84K |
|
|
EXAC
2460
DELISTED
Exactech Inc
EXAC
| $326K | ﹤0.01% |
12,932
+377
| +3% | +$9.7K |
|
|
AGEN
2461
Agenus
AGEN
$329M
| $324K | ﹤0.01% |
4,380
+131
| +3% | +$10.4K |
|
|
ZIXI
2462
DELISTED
Zix Corporation
ZIXI
| $324K | ﹤0.01% |
67,288
+2,489
| +4% | +$12.3K |
|
2463
Surgery Partners
SGRY
$2.08B
| $323K | ﹤0.01% |
16,550
+772
| +5% | +$15K |
|
2464
Winmark
WINA
$1.19B
| $323K | ﹤0.01% |
2,858
+6
| +0.2% | +$687 |
|
|
SNBC
2465
DELISTED
Sun Bancorp Inc
SNBC
| $323K | ﹤0.01% |
13,243
+1,214
| +10% | +$30.5K |
|
2466
Citi Trends
CTRN
$565M
| $322K | ﹤0.01% |
18,947
+576
| +3% | +$10K |
|
|
TNAV
2467
DELISTED
Telenav Inc.
TNAV
| $322K | ﹤0.01% |
37,211
+1,529
| +4% | +$12.8K |
|
|
NCOM
2468
DELISTED
National Commerce Corporation
NCOM
| $322K | ﹤0.01% |
8,789
+442
| +5% | +$16.4K |
|
|
MCF
2469
DELISTED
Contango Oil & Gas Co.
MCF
| $322K | ﹤0.01% |
43,958
+12,676
| +41% | +$99.5K |
|
2470
Lennar Class B
LEN.B
$19.7B
| $321K | ﹤0.01% |
8,252
+930
| +13% | +$33.2K |
|
|
SFE
2471
DELISTED
Safeguard Scientifics, Inc.
SFE
| $321K | ﹤0.01% |
25,261
-1,021
| -4% | -$12.9K |
|
|
CNCE
2472
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $320K | ﹤0.01% |
18,753
+976
| +5% | +$11.7K |
|
|
HZN
2473
DELISTED
Horizon Global Corporation
HZN
| $320K | ﹤0.01% |
23,085
+2,792
| +14% | +$51K |
|
|
NPTN
2474
DELISTED
NEOPHOTONICS CORP
NPTN
| $320K | ﹤0.01% |
35,504
+1,121
| +3% | +$11.7K |
|
|
NVTA
2475
DELISTED
Invitae Corporation
NVTA
| $319K | ﹤0.01% |
28,841
+3,705
| +15% | +$35.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.